Management of elderly patients with glioblastoma-multiforme-a systematic review.

The management of elderly patients with glioblastoma-multiforme (GBM) remains poorly defined with many experts in the past advocating best supportive care, in view of limited evidence on efficacy of more aggressive treatment protocols. There is randomised evidence (NORDIC and NA-O8 studies) to support the use of surgery followed by adjuvant monotherapy with either radiotherapy (RT) using hypofractionated regimes (e.g. 36 Gy in 6 fractions OR 40 Gy in 15 fractions) or chemotherapy with temozolomide (TMZ) in patients expressing methylation of promoter for O6-methylguanine-DNA methyltransferase enzyme. However, the role of combined-modality therapy involving the use of combined RT and TMZ protocols has remained controversial with data from the EORTC (European Organisation for Research and Treatment of Cancer)-NCIC (National Cancer Institute of Canada) studies indicating that patients more than 65 years of age may not benefit significantly from combining standard RT fractionation using 60 Gy in 30 fractions with concurrent and adjuvant TMZ. More recently, randomised data has emerged on combining hypofractionated RT with concurrent and adjuvant TMZ. We provide a comprehensive review of literature with the aim of defining an evidence-based algorithm for management of elderly glioblastoma-multiforme population.

[1]  D. Osoba,et al.  Short‐Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma , 2017, The New England journal of medicine.

[2]  D. Osoba,et al.  A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677). , 2016 .

[3]  G. Pavesi,et al.  Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study , 2016, Journal of Neuro-Oncology.

[4]  D. Cahill,et al.  Glioblastoma care in the elderly , 2016, Cancer.

[5]  G. Mckhann,et al.  The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma. , 2015, World neurosurgery.

[6]  B. Jeremic,et al.  International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Mark D. Johnson,et al.  Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation , 2015, Journal of Neuro-Oncology.

[8]  Laura W. Christianson,et al.  Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients. , 2015, International journal of radiation oncology, biology, physics.

[9]  A. Cenic,et al.  Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. , 2015, Neuro-oncology.

[10]  H. Bai,et al.  Biopsy versus resection in the management of high-grade gliomas in the elderly. , 2015, Neuro-oncology.

[11]  A. Fiorentino,et al.  Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? , 2015, American journal of clinical oncology.

[12]  F. Payer,et al.  Treatment results and outcome in elderly patients with glioblastoma multiforme – A retrospective single institution analysis , 2015, Clinical Neurology and Neurosurgery.

[13]  F. Pasqualetti,et al.  Radio-chemotherapy with temozolomide in elderly patients with glioblastoma. A mono-institutional experience. , 2014, Anticancer research.

[14]  H. Wheeler,et al.  Elderly patients aged 65–75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide , 2014, Journal of Neuro-Oncology.

[15]  H. Duffau,et al.  Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France , 2014, Neurosurgical Review.

[16]  V. Rohde,et al.  Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients , 2013, Clinical Neurology and Neurosurgery.

[17]  Jin-xiang Cheng,et al.  Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis , 2013, PloS one.

[18]  R. Stupp,et al.  Neuro-oncology: In search of molecular markers of glioma in elderly patients , 2013, Nature Reviews Neurology.

[19]  K. Hopkins,et al.  A pilot study of glioblastoma multiforme in elderly patients: Treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival , 2013, Clinical Neurology and Neurosurgery.

[20]  Jacob G. Scott,et al.  Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older , 2012, Cancer.

[21]  Didier Frappaz,et al.  Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. , 2012, The Lancet. Oncology.

[22]  G. Reifenberger,et al.  Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. , 2012, The Lancet. Oncology.

[23]  P. Gutin,et al.  Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma , 2012, Journal of Neuro-Oncology.

[24]  A. Fiorentino,et al.  Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies , 2012, Medical Oncology.

[25]  F. Giangaspero,et al.  Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. , 2012, International journal of radiation oncology, biology, physics.

[26]  B. Fisher,et al.  Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience , 2012, Journal of Neuro-Oncology.

[27]  C. Belka,et al.  Radiotherapy with and without temozolomide in elderly patients with glioblastoma , 2012, Strahlentherapie und Onkologie.

[28]  Jacob G. Scott,et al.  Effectiveness of radiotherapy for elderly patients with glioblastoma. , 2011, International journal of radiation oncology, biology, physics.

[29]  F. Ducray,et al.  Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  K. Franz,et al.  Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  P. Marchetti,et al.  Short-term Radiotherapy followed by Adjuvant Chemotherapy in Poor-Prognosis Patients with Glioblastoma , 2010 .

[32]  A. Brandes,et al.  Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma , 2009, Cancer.

[33]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[34]  Dong Yang,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma , 2008 .

[35]  J. Debus,et al.  Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. , 2008, International journal of radiation oncology, biology, physics.

[36]  V. Tombolini,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients , 2008, Journal of Neuro-Oncology.

[37]  Luc Taillandier,et al.  Radiotherapy for glioblastoma in the elderly. , 2007, The New England journal of medicine.

[38]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[39]  E. Bruera,et al.  Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Brada,et al.  Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  E. Halperin.  Malignant gliomas in older adults with poor prognostic signs. Getting nowhere, and taking a long time to do it. , 1995, Oncology.

[42]  J. Cairncross,et al.  A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. , 1994, International journal of radiation oncology, biology, physics.

[43]  N. Bleehen,et al.  A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. , 1991, British Journal of Cancer.

[44]  G. Sheline,et al.  Radiotherapy for high grade gliomas. , 1990, International journal of radiation oncology, biology, physics.

[45]  P. Ganz,et al.  Karnofsky performance status revisited: reliability, validity, and guidelines. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  V. Esposito,et al.  Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. , 2015, International journal of radiation oncology, biology, physics.

[47]  J. Yeh,et al.  Elderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard- versus abbreviated-course radiotherapy. , 2015, The Permanente journal.

[48]  Jessica A. Tang,et al.  Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. , 2014, Journal of neurosurgery.

[49]  X. Zhang,et al.  A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients , 2013, Journal of Neuro-Oncology.

[50]  P. Marchetti,et al.  Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma. , 2010, Tumori.

[51]  G. Cantore,et al.  Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma , 2008, Journal of Neuro-Oncology.

[52]  Medical Research Council.  Prognostic factors for high-grade malignant glioma: Development of a prognostic index , 2004, Journal of Neuro-Oncology.

[53]  J. Jääskeläinen,et al.  Debulking or biopsy of malignant glioma in elderly people – a randomised study , 2003, Acta Neurochirurgica.

[54]  N. Bleehen,et al.  A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. , 1997, Clinical oncology (Royal College of Radiologists (Great Britain)).